ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Cryoviva Singapore Gets AABB Accreditation for Somatic Cells' Processing, Storage, and Distribution

Singapore, Nov 2, 2021 - (ACN Newswire) - Family cord blood bank Cryoviva Singapore is pleased to announce that it has now been accredited by the Association of the Advancement of Blood & Biotherapies (AABB), formerly known as the American Association of Blood Banks, for both cord blood and somatic cells' banking services. Cryoviva is the first family cord blood bank in Singapore to get accredited by AABB for Somatic Cells' processing, storage, and distribution.

The company had already been accredited by AABB previously for Cord blood collection, storage, processing and distribution, an accreditation that has been successfully extended until September 30, 2023.

The news of the AABB accreditation for both cord blood and somatic cells' services closely follows Cryoviva's recent expansions into the Middle East. The company is now serving families in the UAE and Bahrain, enabling them to store their baby's precious umbilical cord blood at Cryoviva's world-class facilities in Singapore.

"We are indeed proud to get the AABB accreditations and being the first private cord blood bank to get it for somatic cells' processing, storage and distribution. It has been our constant endeavour to offer families the greatest opportunities to benefit from the potential of umbilical cord stem cells," said Rajesh Nair, CEO of Cryoviva Singapore. "Cord tissue storage- in addition to cord blood banking- is a significant step in this regard, which we believe will benefit a lot more families. We will continue to invest in the right technologies, processes and people to ensure we offer the very best service to our valued customers."

"Since commencing our operations in Singapore 7 years ago, Cryoviva has made rapid progress in establishing itself in the family cord blood space. This is another important milestone for us. Besides the company's management and investors, our team of medical experts and lab staff deserve credit for their commitment to quality and excellence," said Dr.Toh Keng Kiat, Medical Director of Cryoviva Singapore and a reputed haematologist.

About Cryoviva Singapore

Established in 2014, Cryoviva (https://cryoviva.com.sg) is a reputed family cord blood bank in Singapore. The company is part of an international group that is backed by reputed multinational investor organisations. Cryoviva has successfully stored over 160,000 umbilical cord blood units from both local and expat clients at our state-of-the-art laboratory and storage facility in Singapore. This facility is MoH-licensed, AABB accredited and IS ISO 9001:2015 QMS Certified, testaments to the stringent processes and quality standards that we adhere to. Thanks to being centrally located and proximity to most major maternity hospitals in Singapore, cord blood samples reach our facilities very quickly and efficiently to ensure top quality maintenance upon storage.

Media Contact:
Krish Sharma, Sr.Manager, Marketing & Operations
Tel: +65-9651 7080
E-mail: krish@cryoviva.com.sg

Source: Cryoviva Singapore

Copyright 2021 ACN Newswire . All rights reserved.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.